4-N-benzyl-2-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazine-2,4-diamine;4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;bis(4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine);4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine

C123H132N38O5 — CID 158328449

IUPAC4-N-benzyl-2-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazine-2,4-diamine;4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;bis(4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine);4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine
SMILESC1=C(c2ccco2)CN=C1Nc1nc(NCc2ccccc2)nc(N2CCCC2)n1.C1=C(c2ccco2)CN=C1Nc1nc(NCc2ccccc2)nc(N2CCN(c3ccccc3)CC2)n1.C1=C(c2ccco2)CN=C1Nc1nc(NCc2ccccc2)nc(N2CCN(c3ccccc3)CC2)n1.C1=C(c2ccco2)CN=C1Nc1nc(NCc2ccccc2)nc(N2CCOCC2)n1.CN1CCCN(c2nc(NCc3ccccc3)nc(NC3=NCC(C4CC4)=C3)n2)CC1
InChIInChI=1S/2C28H28N8O.C23H30N8.C22H23N7O2.C22H23N7O/c2*1-3-8-21(9-4-1)19-30-26-32-27(31-25-18-22(20-29-25)24-12-7-17-37-24)34-28(33-26)36-15-13-35(14-16-36)23-10-5-2-6-11-23;1-30-10-5-11-31(13-12-30)23-28-21(25-15-17-6-3-2-4-7-17)27-22(29-23)26-20-14-19(16-24-20)18-8-9-18;1-2-5-16(6-3-1)14-24-20-26-21(28-22(27-20)29-8-11-30-12-9-29)25-19-13-17(15-23-19)18-7-4-10-31-18;1-2-7-16(8-3-1)14-24-20-26-21(28-22(27-20)29-10-4-5-11-29)25-19-13-17(15-23-19)18-9-6-12-30-18/h2*1-12,17-18H,13-16,19-20H2,(H2,29,30,31,32,33,34);2-4,6-7,14,18H,5,8-13,15-16H2,1H3,(H2,24,25,26,27,28,29);1-7,10,13H,8-9,11-12,14-15H2,(H2,23,24,25,26,27,28);1-3,6-9,12-13H,4-5,10-11,14-15H2,(H2,23,24,25,26,27,28)
InChIKeyGPRYLBOXUNXRDX-UHFFFAOYSA-N
MW2222.67 g/mol
LogP17.81
Rot. Bonds32

About 4-N-benzyl-2-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazine-2,4-diamine;4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;bis(4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine);4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine

4-N-benzyl-2-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazine-2,4-diamine;4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;bis(4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine);4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine (PubChem CID 158328449) has the molecular formula C123H132N38O5 and a molecular weight of 2222.67 g/mol. Its IUPAC name is 4-N-benzyl-2-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazine-2,4-diamine;4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;bis(4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine);4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine.

Molecular Properties

Compound Name4-N-benzyl-2-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazine-2,4-diamine;4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;bis(4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine);4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine
PubChem CID158328449
Molecular FormulaC123H132N38O5
Molecular Weight2222.67 g/mol
Exact Mass2221.12
IUPAC Name4-N-benzyl-2-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazine-2,4-diamine;4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;bis(4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine);4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine
SMILESC1=C(c2ccco2)CN=C1Nc1nc(NCc2ccccc2)nc(N2CCCC2)n1.C1=C(c2ccco2)CN=C1Nc1nc(NCc2ccccc2)nc(N2CCN(c3ccccc3)CC2)n1.C1=C(c2ccco2)CN=C1Nc1nc(NCc2ccccc2)nc(N2CCN(c3ccccc3)CC2)n1.C1=C(c2ccco2)CN=C1Nc1nc(NCc2ccccc2)nc(N2CCOCC2)n1.CN1CCCN(c2nc(NCc3ccccc3)nc(NC3=NCC(C4CC4)=C3)n2)CC1
InChIInChI=1S/2C28H28N8O.C23H30N8.C22H23N7O2.C22H23N7O/c2*1-3-8-21(9-4-1)19-30-26-32-27(31-25-18-22(20-29-25)24-12-7-17-37-24)34-28(33-26)36-15-13-35(14-16-36)23-10-5-2-6-11-23;1-30-10-5-11-31(13-12-30)23-28-21(25-15-17-6-3-2-4-7-17)27-22(29-23)26-20-14-19(16-24-20)18-8-9-18;1-2-5-16(6-3-1)14-24-20-26-21(28-22(27-20)29-8-11-30-12-9-29)25-19-13-17(15-23-19)18-7-4-10-31-18;1-2-7-16(8-3-1)14-24-20-26-21(28-22(27-20)29-10-4-5-11-29)25-19-13-17(15-23-19)18-9-6-12-30-18/h2*1-12,17-18H,13-16,19-20H2,(H2,29,30,31,32,33,34);2-4,6-7,14,18H,5,8-13,15-16H2,1H3,(H2,24,25,26,27,28,29);1-7,10,13H,8-9,11-12,14-15H2,(H2,23,24,25,26,27,28);1-3,6-9,12-13H,4-5,10-11,14-15H2,(H2,23,24,25,26,27,28)
InChIKeyGPRYLBOXUNXRDX-UHFFFAOYSA-N
XLogP17.81
TPSA463.16 Ų
H-Bond Donors10
H-Bond Acceptors43
Rotatable Bonds32
Heavy Atoms166
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002222.67
LogP ≤ 517.81
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1043

Analyze 4-N-benzyl-2-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazine-2,4-diamine;4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;bis(4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine);4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-N-benzyl-2-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazine-2,4-diamine;4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;bis(4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine);4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine?
The IUPAC name of 4-N-benzyl-2-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazine-2,4-diamine;4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;bis(4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine);4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine (CID 158328449) is 4-N-benzyl-2-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazine-2,4-diamine;4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;bis(4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine);4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine.
What is the SMILES notation for 4-N-benzyl-2-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazine-2,4-diamine;4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;bis(4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine);4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine?
The canonical SMILES for 4-N-benzyl-2-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazine-2,4-diamine;4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;bis(4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine);4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine is C1=C(c2ccco2)CN=C1Nc1nc(NCc2ccccc2)nc(N2CCCC2)n1.C1=C(c2ccco2)CN=C1Nc1nc(NCc2ccccc2)nc(N2CCN(c3ccccc3)CC2)n1.C1=C(c2ccco2)CN=C1Nc1nc(NCc2ccccc2)nc(N2CCN(c3ccccc3)CC2)n1.C1=C(c2ccco2)CN=C1Nc1nc(NCc2ccccc2)nc(N2CCOCC2)n1.CN1CCCN(c2nc(NCc3ccccc3)nc(NC3=NCC(C4CC4)=C3)n2)CC1.
What is the InChIKey of 4-N-benzyl-2-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazine-2,4-diamine;4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;bis(4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine);4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine?
The InChIKey is GPRYLBOXUNXRDX-UHFFFAOYSA-N. The full InChI is InChI=1S/2C28H28N8O.C23H30N8.C22H23N7O2.C22H23N7O/c2*1-3-8-21(9-4-1)19-30-26-32-27(31-25-18-22(20-29-25)24-12-7-17-37-24)34-28(33-26)36-15-13-35(14-16-36)23-10-5-2-6-11-23;1-30-10-5-11-31(13-12-30)23-28-21(25-15-17-6-3-2-4-7-17)27-22(29-23)26-20-14-19(16-24-20)18-8-9-18;1-2-5-16(6-3-1)14-24-20-26-21(28-22(27-20)29-8-11-30-12-9-29)25-19-13-17(15-23-19)18-7-4-10-31-18;1-2-7-16(8-3-1)14-24-20-26-21(28-22(27-20)29-10-4-5-11-29)25-19-13-17(15-23-19)18-9-6-12-30-18/h2*1-12,17-18H,13-16,19-20H2,(H2,29,30,31,32,33,34);2-4,6-7,14,18H,5,8-13,15-16H2,1H3,(H2,24,25,26,27,28,29);1-7,10,13H,8-9,11-12,14-15H2,(H2,23,24,25,26,27,28);1-3,6-9,12-13H,4-5,10-11,14-15H2,(H2,23,24,25,26,27,28).
What are the key properties of 4-N-benzyl-2-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazine-2,4-diamine;4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;bis(4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine);4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine?
4-N-benzyl-2-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazine-2,4-diamine;4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;bis(4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine);4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine has a molecular weight of 2222.67 g/mol, XLogP of 17.81, 32 rotatable bonds, 10 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for 4-N-benzyl-2-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazine-2,4-diamine;4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;bis(4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazine-2,4-diamine);4-N-benzyl-2-N-[3-(furan-2-yl)-2H-pyrrol-5-yl]-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine is sourced from PubChem (CID 158328449), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).